The Vasculature as a Target in the Treatment of Pulmonary Emphysema

Golpon, H. A.; Voelkel, N. F.
June 2006
Current Drug Targets;Jun2006, Vol. 7 Issue 6, p737
Academic Journal
Pulmonary emphysema, a major component of chronic obstructive pulmonary diseases, is a highly prevalent progressive tissue-destructive disease, with no effective treatments. The interplay between inflammation, matrix proteolysis, oxidative stress and apoptosis might account for the irreversible progression of the disease. Recent investigations have underlined the importance of the lung vasculature in the pathobiology of chronic obstructive pulmonary diseases offering new therapeutic strategies. This review will focus on the pulmonary microvessels as a target in the treatment of pulmonary emphysema.


Related Articles

  • Thioredoxin-1 Protects against Neutrophilic Inflammation and Emphysema Progression in a Mouse Model of Chronic Obstructive Pulmonary Disease Exacerbation. Tanabe, Naoya; Hoshino, Yuma; Marumo, Satoshi; Kiyokawa, Hirofumi; Sato, Susumu; Kinose, Daisuke; Uno, Kazuko; Muro, Shigeo; Hirai, Toyohiro; Yodoi, Junji; Mishima, Michiaki // PLoS ONE;Nov2013, Vol. 8 Issue 11, p1 

    Background: Exacerbations of chronic obstructive pulmonary disease (COPD) are characterized by acute enhancement of airway neutrophilic inflammation under oxidative stress and can be involved in emphysema progression. However, pharmacotherapy against the neutrophilic inflammation and emphysema...

  • Apoptosis and Bcl-2 family proteins, taken to chronic obstructive pulmonary disease. Huihui Zeng; Xianglong Kong; Hong Peng; Yan Chen; Shan Cai; Hong Luo; Ping Chen // European Review for Medical & Pharmacological Sciences;2012, Vol. 16 Issue 6, p711 

    Background: Chronic obstructive pulmonary disease (COPD) is characterized by chronic inflammation of airway and emphysema, progressive destruction of lung parenchyma and alveolar structure. Apoptosis of pulmonary or extrapulmonary cells has been observed in COPD and has been shown to contribute...

  • Pathogenesis of chronic obstructive pulmonary disease. Tuder, Rubin M.; Petrache, Irina // Journal of Clinical Investigation;Aug2012, Vol. 122 Issue 8, p2749 

    The current epidemic of chronic obstructive pulmonary disease (COPD) has produced a worldwide health care burden, approaching that imposed by transmittable infectious diseases. COPD is a multidimensional disease, with varied intermediate and clinical phenotypes. This Review discusses the...

  • Adenosine Deaminase Activity in COPD Patients and Healthy Subjects. Goodarzi, Mohammad Taghi; Abdi, Mohammad; Tavilani, Heidar; Nadi, Ebrahim; Rashidi, Mojtaba // Iranian Journal of Allergy, Asthma & Immunology;2010, Vol. 9 Issue 1, p7 

    Chronic obstructive pulmonary disease (COPD) has been defined by the Global Initiative for Chronic Obstructive Lung Disease (GOLD), as a disease state characterized by airflow limitation which is not fully reversible. COPD consists of emphysema which is the destruction and inflammation of the...

  • Emphysema is associated with increased inflammation in lungs of atherosclerosis-prone mice by cigarette smoke: implications in comorbidities of COPD. Arunachalam, Gnanapragasam; Sundar, Isaac K.; Jae-woong Hwang; Hongwei Yao; Rahman, Irfan // Journal of Inflammation;2010, Vol. 7, p34 

    Background: Chronic obstructive pulmonary disease is associated with numerous vascular effects including endothelial dysfunction, arterial stiffness and atherogenesis. It is also known that a decline in lung function is associated with increased cardiovascular comorbidity in smokers. The...

  • Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study. Miniati, Massimo; Monti, Simonetta; Basta, Giuseppina; Cocci, Franca; Fornai, Edo; Bottai, Matteo // Respiratory Research;Jan2011, Vol. 12 Issue 1, p37 

    Background: The receptor for advanced glycation end products (RAGE) is a multiligand signal transduction receptor that can initiate and perpetuate inflammation. Its soluble isoform (sRAGE) acts as a decoy receptor for RAGE ligands, and is thought to afford protection against inflammation. With...

  • Chronic obstructive pulmonary disease · 2: Pathology and biochemistry of emphysema. Hogg, J.C.; Senior, R.M. // Thorax;Sep2002, Vol. 57 Issue 9, p830 

    Part 2. Examines the pathology and biochemistry of emphysema. Cells responsible for the degradation of extracellular matrix in emphysema; Proteinase-antiproteinase hypothesis; Proteinases involved in alveolar septal destruction.

  • Influence of lung volume reduction surgery (LVRS) on health related quality of life in patients with chronic obstructive pulmonary disease. Goldstein, R.S.; Todd, T.R.J.; Guyatt, G.; Keshavjee, S.; Dolmage, T.E.; van Rooy, S.; Krip, B.; Maltais, F.; LeBlanc, P.; Pakhale, S.; Waddell, T.K. // Thorax;May2003, Vol. 58 Issue 5, p405 

    Background: The clinical value of LVRS has been questioned in the absence of trials comparing it with pulmonary rehabilitation, the prevailing standard of care in COPD. Patients with heterogeneous emphysema are more likely to benefit from volume reduction than those with homogeneous...

  • The composition of cigarette smoke determines inflammatory cell recruitment to the lung in COPD mouse models. JOHN, Gerrit; KOHSE, Katrin; ORASCHE, Jürgen; REDA, Ahmed; SCHNELLE-KREIS, Jürgen; ZIMMERMANN, Ralf; SCHMID, Otmar; EICKELBERG, Oliver; Önder YILDIRIM, Ali // Clinical Science;Feb2014, Vol. 126 Issue 3, p207 

    COPD (chronic obstructive pulmonary disease) is caused by exposure to toxic gases and particles, most often CS (cigarette smoke), leading to emphysema, chronic bronchitis, mucus production and a subsequent decline in lung function. The disease pathogenesis is related to an abnormal CS-induced...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics